Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lifco on acquisition of Rapid Granulator
Mandate

Vinge advises Lifco on acquisition of Rapid Granulator

February 20, 2015

Vinge is advising Lifco AB (publ) in connection with the acquisition of Rapid Granulator AB. Lifco acquires and develops market-leading niched operations within the three business areas dental, demolition & tools and systems solutions. Lifco has approximately 100 companies in 30 countries and in 2013, the group’s net sales amounted to more than SEK 6 billion. Rapid Granulator is a leading global manufacturer of granulators for in-plant recycling of plastic waste and in 2014, Rapid Granulator reported net sales of approximately MSEK 300.

The Vinge team advising Lifco AB (publ) includes partner Erik Gabrielson and counsel Kristian Ford together with inter alia associates Henrik Jonsson, Karolina Tjärnberg and Mattias Sköld. Partner Ingela Malmborg provided environmental law advice.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025